Radiofrequency Ablation Versus Adrenalectomy for Adenoma in Patients With Primary Aldosteronism and Hypertension
NCT07470580 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 134
Last updated 2026-06-11
Summary
Primary aldosteronism (PA) is characterized by hypertension, frequent hypokalaemia, and an inappropriately high aldosterone-to-renin ratio (ARR). Aldosterone-producing adenoma (APA or Conn syndrome) is one of the main causes of primary aldosteronism. Laparoscopic (LA) total-adrenalectomy or adenoma selective is an option to normalize or at least improve blood pressure (BP) control, hypokalaemia, and normalize the ARR. However, the reported result of surgery is around 50% of clinical cure rate with an overall complication rate of 5 to 14% whereas hormonal success reached around 95%.
More recently, radiofrequency ablation (RFA) has been used for patients with primary aldosteronism and unilateral adenoma.
Investigator Team assume that treatment of unilateral PA by RFA could achieve similar efficacy to treatment by LA, with potentially less adverse events, and could be a more cost-efficient procedure.
Conditions
- Primary Aldosteronism Due to Conn Adenoma
- Radiofrequency Ablation Treatment
- Adrenalectomy
Interventions
- PROCEDURE
-
RFA -radiofrequency ablation
Under real-time multidetector CT-guidance, the patients will be put in either prone or lateral decubitus position to choose for the optimal access route for RFA needle electrode. Under multidetector CT guidance, patients would be treated with regard to optimal RFA needle access route with a hydrodissection or aero dissection if necessary. 2 types of generator (Boston Scientific RF 3000, and Ablatech Amica) and of needle electrodes (Leveen-type extendable, Ablatech) will be used according to the routine care of the centers
- PROCEDURE
-
Adrenalectomy
Adrenalectomy may be performed using a laparoscopic or open approach. In either approach, the gland may be approached transabdominally or retroperitoneally. The choice of surgical approach depends on the size and nature of the lesion, the patient's general characteristics and the expertise of the surgeon. Actually, laparoscopic adrenalectomy is considered as the gold standard treatment for the selected patients
Sponsors & Collaborators
-
University Hospital, Toulouse
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-06-05
- Primary Completion
- 2030-06-01
- Completion
- 2030-06-01
Countries
- France
Study Locations
More Related Trials
-
Transplant Renal Artery Stenosis: Observation Versus Stenting
NCT05046496 ·Status: UNKNOWN ·Phase: NA
-
The Effect of Eplerenone on the Evolution of Vasculopathy in Renal Transplant Patients.
NCT04450953 ·Status: RECRUITING ·Phase: PHASE3
-
Transplantation of Reconstructed Renal Allografts Following Ex-Vivo Partial Nephrectomy
NCT05725421 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Absence of Steroid in Renal Transplantation and Digital Fibrosis Observation
NCT01541176 ·Status: COMPLETED ·Phase: PHASE4
-
Retrospective Study of Patients Undergoing Percutaneous Intervention of the Transplant Renal Artery Stenosis
NCT04225338 ·Status: COMPLETED
-
A 15-year Single Center Experience of Endovascular Treatment of Transplant Renal Artery Stenosis
NCT03477071 ·Status: COMPLETED
-
Investigating a Novel Modifiable Factor Affecting Renal Function After Partial Nephrectomy: Cortical Renorrhaphy
NCT02131376 ·Status: TERMINATED ·Phase: NA
-
Long-term Cardiovascular Risk Following Successful Renal Transplantation
NCT01728012 ·Status: COMPLETED
-
The Outcomes of Living Donor Robotic Assisted Kidney Transplantation
NCT06577805 ·Status: RECRUITING
-
Obesity Surgery and Kidney Transplant for Patients With Obesity and Renal Failure
NCT02128802 ·Status: COMPLETED ·Phase: NA
-
Prevalence of Adrenal Insufficiency in Kidney Transplanted Patients in Glucocorticoid Treatment
NCT03136562 ·Status: COMPLETED
-
Arterial Stiffness and Calcifications in Incident Renal Transplant Recipients
NCT00547040 ·Status: COMPLETED
-
StOPping Hypertension and imprOving Children's Lives After KidnEy TranSplantation
NCT06589947 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Renal Allograft Fibrosis Study
NCT05058170 ·Status: ENROLLING_BY_INVITATION
-
Medical Economic Evaluation and of Quality of Life of the Kidney Living Donors.
NCT02830568 ·Status: COMPLETED
-
Proteinuria and Renal Perfusion in Renal Transplant Recipients
NCT06051812 ·Status: ACTIVE_NOT_RECRUITING
-
Angiotensin 2 for AKI After OLT
NCT04592744 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Access to Kidney Transplant of Obese Patients Beginning Dialysis
NCT04748770 ·Status: RECRUITING
-
A Study Comparing Outcomes of Kidney Transplants in Patients on Steroids Versus Those Who Discontinue Steroids
NCT00273559 ·Status: UNKNOWN
-
Evaluation of Iliac and Renal Artery for Mechanism of Intracranial Aneurysm in ADPKD
NCT03726463 ·Status: UNKNOWN
-
Donor Recipient Kidney Function Following Open Surgical vs. Laparoscopic Kidney Donation
NCT00100516 ·Status: COMPLETED
-
Bone and Cardiovascular Disease After Kidney Transplant
NCT02751099 ·Status: UNKNOWN
-
Melatonin and Adiponectin in Hypertensive Kidney Transplant
NCT00498576 ·Status: COMPLETED
-
Fibrin Based Adhesive for the Prevention of Surgical Complications in the Kidney Transplantation
NCT01631448 ·Status: COMPLETED ·Phase: PHASE3
-
Post Kidney Transplant Nocturnal Hypertension Prevalence and Management Study
NCT01120613 ·Status: WITHDRAWN ·Phase: NA